Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Brachytherapy
|
September 16, 2018
Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images
Kibrom Berihu Girum, Alain Lalande, Magali Quivrin, et al.
Cancers
|
March 29, 2023
Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation
Sébastien Meunier, Alexandre Frontczak, Loïc Balssa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 1, 2015
Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse
Coraline Bednarek, Gilles Crehange, Magali Quivrin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 14, 2023
Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer
Oumar Billa, Franck Bonnetain, Jérôme Chamois, et al.
Cancers
|
August 7, 2021
Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer
Oumar Billa, Franck Bonnetain, Jérôme Chamois, et al.
Frontiers in Oncology
|
November 11, 2024
Nodal radiotherapy for prostate adenocarcinoma recurrence: predictive factors for efficacy
Anna Gueiderikh, Jérémy Baude, David Baron, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 13, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group
Kanta Ka, Renaud Schiappa, Mario Terlizzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 14, 2026
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial
Morgan Michalet, Philippe Ronchin, Thomas Reynaud, et al.
Journal of Cardiovascular Electrophysiology
|
November 29, 2023
Cardiac stereotactic radiation therapy for refractory ventricular arrhythmias in patients with left ventricular assist devices
Karim Benali, Michael S Lloyd, Andranik Petrosyan, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Brachytherapy
|
September 16, 2018
Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images
Kibrom Berihu Girum, Alain Lalande, Magali Quivrin, et al.
Cancers
|
March 29, 2023
Elevated Baseline Neutrophil Count Correlates with Worse Outcomes in Patients with Muscle-Invasive Bladder Cancer Treated with Chemoradiation
Sébastien Meunier, Alexandre Frontczak, Loïc Balssa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 1, 2015
Mapping of failures after radiochemotherapy in patients with non-metastatic esophageal cancer: A posteriori analysis of the dose distribution in the sites of loco-regional relapse
Coraline Bednarek, Gilles Crehange, Magali Quivrin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 14, 2023
Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer
Oumar Billa, Franck Bonnetain, Jérôme Chamois, et al.
Cancers
|
August 7, 2021
Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer
Oumar Billa, Franck Bonnetain, Jérôme Chamois, et al.
Frontiers in Oncology
|
November 11, 2024
Nodal radiotherapy for prostate adenocarcinoma recurrence: predictive factors for efficacy
Anna Gueiderikh, Jérémy Baude, David Baron, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 13, 2023
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group
Kanta Ka, Renaud Schiappa, Mario Terlizzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 14, 2026
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial
Morgan Michalet, Philippe Ronchin, Thomas Reynaud, et al.
Journal of Cardiovascular Electrophysiology
|
November 29, 2023
Cardiac stereotactic radiation therapy for refractory ventricular arrhythmias in patients with left ventricular assist devices
Karim Benali, Michael S Lloyd, Andranik Petrosyan, et al.
European Urology Oncology
|
February 8, 2023
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study
David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al.
Page
of 3